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CASE REPORT
Lupus is a systemic autoimmune disease of an unknown origin, and systemic lupus erythematosus (SLE) can
be triggered by numerous stimuli. Bee venom therapy is an alternative therapy that is believed to be effective for
various kinds of arthritis. We present here a case of a 49-year-old female who experienced a new onset lupus
after undergoing bee venom therapy, and this looked like a case of angioedema. The patient was successfully
treated with high dose steroids and antimalarial drugs. We discuss the possibility of bee venom contributing to the
development of SLE, and we suggest that such treatment should be avoided in patients with lupus. (Korean J
Intern Med 2009;24:283-285)
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INTRODUCTION
Lupus is a systemic autoimmune disease of an unknown
origin, and systemic lupus erythematosus (SLE) is known
to be under the immunological influence of Th2 [1]. Bee
venom therapy is an alternative therapy that is believed to
be effective for various kinds of arthritis [2]. We present
here a case of a new onset SLE after the patient underwent
bee venom therapy, and the clinical picture resembled
that of angioedema.
CASE REPORT
During November 2004, a 49-year-old female patient
visited the rheumatology clinic at Korea University Medical
Center. She complained of diffuse muscle pain and weak-
ness, with arthralgia on her hands, feet, elbows and knees
that had persisted for 6 months. She had equivocal morning
stiffness and physical findings. With the possibility of
autoimmune disease, she was offered laboratory evaluation
along with analgesic treatment, but she declined. One
month later, the patient was admitted to the infectious
diseases division with the chief complaint of dysuria and
fever. She was evaluated and treated under the impression
of having a urinary tract infection, but treatment was
ineffective and any microbial evidence could not be found.
She was then referred to the Division of Rheumatology for
assessment of her fever and pan-cytopenia. She was found
to have undergone a trial of bee venom therapy on her
knees 10 days before the admission, which did relieve her
arthralgia. Her fever was reported to have begun shortly
after the treatment. 
On inspection, the patient was ill looking and had an
edematous, puffy face with swollen eyelids, giving the
impression of angioedema. She also had a generalized
erythematous papular rash, especially on the trunk (Fig. 1.)
There was only a subtle local reaction on the bee venom
injection site. Oral thrush was also found, which was later
confirmed to be oral candidiasis. Her vital signs were a
body temperature of 38.9˚C, a blood pressure of 160/90
mmHg, a heart rate of 96/minutes and a respiration rate
of 20/minutes. Suspicious crackles were heard on both
lower lungs. She was initially found to have mild costover-tebral tenderness, but this disappeared later. Her laboratory
findings were a white blood cell count of 2,340/µL
(lymphocytes 10%, stab neutrophils 78%, neutrophils
8%, monocytes 1%, eosinophils/basophils 0%, myelocytes
3%), a hemoglobin level of 8.0 g/dL and a platelet count
of 177,000/µL. The erythrocyte sedimentation rate (ESR)
was 57 mm/hours (reference, 0-20 mm/hours) and the C-
reactive protein was 11.1 mg/dL (reference, 0-0.6 mg/dL).
The hepatic transaminase levels were elevated (AST 128
IU/L and ALT 41 IU/L). The renal function tests were
normal and neither sediments nor protein were found
on spot urine analysis. Three days after admission the
WBC and platelet counts fell to 1,240/µL and 70,000/µL,
respectively, and antinuclear antibody tests revealed an
1:1280 homogenous pattern with the presence of
extractable nuclear antigens (ENA) like anti-Ro (3+), La
(1+), RNP (3+), nucleosomes (3+), Sm (+/-) and histone
(-), according to the immunoblot method. Her anti-ds-
DNA titer was 73 IU/mL (reference, 0-5.3 IU/mL) and the
complement levels were C3: 34.7/C4: 13.6 mg/dL (reference,
88-201/ 16-47 mg/dL). Hypergammaglobulinemia
was also noted. Interestingly, the IgE levels was
elevated (1,364 IU/mL [reference, 0-20 IU/mL]), but
radioallergosorbent tests (RAST) for honeybee, yellow
hornet and common wasp allergens were negative (class
0). Other autoantibodies like rheumatoid factor, ANCA,
and anti-phospholipid antibodies were not detected. Her
chest X-ray showed infiltrations in the right lower lung
region suggestive of bronchitis, but she did not produce
sputum. Abdominal sonograms revealed only a mild to
moderate fatty liver, without splenomegaly. Pathologic
examination of the skin lesions revealed leukocytoclastic
vasculitis (Fig. 2). 
With the findings of facial rash, pancytopenia and
the presence of ANA and specific autoantibodies, the
diagnosis of a new onset lupus was made, which seemed
to be triggered by the bee venom therapy, and she was
treated with intravenous pulse steroids (methylpred-
nisolone 1 g for 1 day) and subsequent high dose oral
steroids (prednisolone 1 mg/kg) with hydroxychloroquine
(400 mg/day). Empirical antibiotics, with oral fluconazole
for her oral candidiasis, were maintained during the
treatment period. Prompt defeversence was noted and the
rash subsided within a few days. She did suffer a compli-
cation of delirium during the treatment period, which was
probably due to the high doses of steroids. However the
pancytopenia along with her clinical state improved, and
she was discharged 10 days after admission, relatively
symptom-free. The chest radiographs improved during
the treatment period. She was found to have complete
cutaneous resolution at the first visit one week later, but
she was lost to further follow-up.
DISCUSSION
The idea of using bee venom as a treatment for arthritic
symptoms is not a new one, and it is thought to have
originated during ancient times [3]. Bee venom is effective
in murine arthritic models [4,5] and it has also shown
effectiveness in human trials [2]. Its effectiveness is thought
to be mediated through inhibition of macrophages and
lymphocytes, which leads to decreased IL-1/IL-2 pro-
duction and inhibition of NF-κb [3]. In addition, bee
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Figure 1. Rash on the back of the patient. Diffuse erythematous
papular lesions are noted.
Figure 2. Microscopic view of the skin biopsy specimen (H-E
stain, ×400). Leukocytoclastic vasculitis is noted.venom’s anti-nociceptive effects were found to be mediated
though alpha-2 adrenoceptors [6]. At the same time, it is
also well known that bee venom can inflict severe compli-
cations such as anaphylaxis [7]. We cannot be entirely sure
of the role of bee venom in our patient because rechallenge
experiments could not be done. Also, the possibility of
having an underlying infection as a precipitating factor
cannot be totally refuted. However, considering the
temporal sequence of the patient’s clinical history, it is
likely that a mild subclinical level of lupus activity must
have been ongoing, and it seems very likely that the
venom triggered the borderline disease into a full-blown
onset of overt lupus. As there was no microbial evidence
except oral candidiasis and no response to antimicrobial
therapy, the influence of infection (if any) seems to be
small. There are very few reports of lupus triggered by
bee stings, with only one report of subacute cutaneous
lupus that was triggered by a wasp sting [8]. Our case is
noteworthy for this as well.
It should be noted that the patient’s IgE levels were
high. As mentioned above, lupus is traditionally thought
to be related to Th2 immunity, which is also associated
with allergic diseases. There is evidence that the IgE levels
correlate with lupus activity [9], so it may be postulated
that the bee venom induced an immune response that
most likely involved Th2, and this tipped the balance to
the full development of lupus. Since no venom-specific
antibodies were detected, the precise mechanism could
not be clearly defined.
In conclusion, although bee venom therapy may be
effective, taking a careful pre-treatment history and
clinical evaluation must be done before starting treatment.
It also should be noted that bee venom therapy may cause
a flare-up of lupus, and this can happen in previously
diagnosed patients, so prudence is needed before treating
such patients.
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